Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Goepfert

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|March 15, 2024
Contralateral versus ipsilateral vaccine boosting for COVID-19: considering the broader scientific landscapePaul Goepfert
F1000Research|July 21, 2018
Understanding the CD8 T-cell response in natural HIV controlSushma Boppana, Paul Goepfert
Infectious Disease Clinics of North America|October 8, 2014
Human immunodeficiency virus vaccinesPaul Goepfert, Anju Bansal
Annals of Internal Medicine|November 23, 2020
Web Exclusive. Annals On Call - A Primer on COVID-19 VaccinesRobert M Centor, Paul Goepfert
AIDS Research and Human Retroviruses|November 12, 2014
Short communication: Plasmacytoid dendritic cells from HIV-1 Elite Controllers maintain a gut-homing phenotype associated with immune activationHaiying Li, Paul Goepfert, R Keith Reeves
Journal of Virology|October 25, 2019
Cross-Reactive CD8 T-Cell Responses Elicited by Adenovirus Type 5-Based HIV-1 Vaccines Contributed to Early Viral Evolution in Vaccine Recipients Who Became InfectedSushma Boppana, Andrew Fiore-Gartland, Anju Bansal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2024
Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2Skye Opsteen, Tim Fram, Jacob K Files, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2026
IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal Influenza infections in immunocompromised patientsPaul Goepfert, Morgan J Katz, Daniel Kaul, et al.
Plos One|November 19, 2010
Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodiesMichael Vaine, Shixia Wang, Qin Liu, et al.
Journal of Medical Virology|July 19, 2006
Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infectionJie Yu, Huiyuan Chen, Helen Horton, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|March 15, 2024
Contralateral versus ipsilateral vaccine boosting for COVID-19: considering the broader scientific landscapePaul Goepfert
F1000Research|July 21, 2018
Understanding the CD8 T-cell response in natural HIV controlSushma Boppana, Paul Goepfert
Infectious Disease Clinics of North America|October 8, 2014
Human immunodeficiency virus vaccinesPaul Goepfert, Anju Bansal
Annals of Internal Medicine|November 23, 2020
Web Exclusive. Annals On Call - A Primer on COVID-19 VaccinesRobert M Centor, Paul Goepfert
AIDS Research and Human Retroviruses|November 12, 2014
Short communication: Plasmacytoid dendritic cells from HIV-1 Elite Controllers maintain a gut-homing phenotype associated with immune activationHaiying Li, Paul Goepfert, R Keith Reeves
Journal of Virology|October 25, 2019
Cross-Reactive CD8 T-Cell Responses Elicited by Adenovirus Type 5-Based HIV-1 Vaccines Contributed to Early Viral Evolution in Vaccine Recipients Who Became InfectedSushma Boppana, Andrew Fiore-Gartland, Anju Bansal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2024
Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2Skye Opsteen, Tim Fram, Jacob K Files, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2026
IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal Influenza infections in immunocompromised patientsPaul Goepfert, Morgan J Katz, Daniel Kaul, et al.
Plos One|November 19, 2010
Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodiesMichael Vaine, Shixia Wang, Qin Liu, et al.
Journal of Medical Virology|July 19, 2006
Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infectionJie Yu, Huiyuan Chen, Helen Horton, et al.
Pageof 6